HAIXI PHARMA (02637) has announced that on April 29, 2026, the board of directors passed a resolution proposing the adoption of a share incentive plan applicable to the company's H-shares. The share incentive plan is designed to further establish and improve the company's long-term incentive mechanism, fully motivate core employees, and effectively align the interests of the company's shareholders, the company itself, and individual employees, so that all parties work together to promote the company's sustainable and healthy development.